CMV in kidney transplants in the tacrolimus-mycophenolate era

Transplant Proc. 2001 Feb-Mar;33(1-2):1196-7. doi: 10.1016/s0041-1345(00)02383-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / therapeutic use
  • Cytomegalovirus Infections / etiology*
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / prevention & control
  • Ganciclovir / therapeutic use
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Kidney Transplantation*
  • Mycophenolic Acid / adverse effects*
  • Mycophenolic Acid / analogs & derivatives
  • Retrospective Studies
  • Tacrolimus / adverse effects*

Substances

  • Antiviral Agents
  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Ganciclovir
  • Tacrolimus